Printer Friendly

Parkinson's disease.

Title: KNGF KNGF Koninklijk Nederlands Geleidehonden Fonds (Royal Dutch Guide Dog Foundation).  Guidelines for Physical Therapy in Patients with Parkinson's Disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. . Date of latest update: June 2004, published in English in October 2006. Date of next update: 2009. Patient group: Adults with Parkinson's disease. Intended audience: Physical therapists and referring physicians. Additional versions: Nil. Expert working group: Eleven professionals from the Netherlands comprised the guideline development group. This included physical therapists, human movement scientists, epidemiologists, exercise therapists, and a neurologist. Funded by: The Dutch Parkinson's Disease Association. Consultation with: The Royal Dutch Society for Physical Therapy, the Dutch Society for Physical Therapists in Geriatrics, the Dutch Society for Exercise Therapists, the Dutch Institute of Allied Health Care, and the Dutch Parkinson's Disease Association. A draft of the original guideline was circulated to a secondary guideline development group comprising external professionals or members of relevant professional organisations. The draft guidelines were also assessed by 50 physical therapists and a panel of patients. Approved by: The Royal Dutch Society for Physical Therapy. Location:

Description: 92 page document, including 5 appendices and 175 references. This guideline comprises two main sections. The first (pp 5-14) provides non-referenced clinical practice guidelines clinical practice guidelines Clinical policies, practice guidelines, practice parameters, practice policies Medtalk Systematically developed statements to assist practitioner and Pt decisions about appropriate health care for specific clinical circumstances. See Psychology.  which provide information about Parkinson's disease (PD), diagnostic processes (eg. outcome measures), and therapeutic processes. The second section (pp 14-49) provides a review of the evidence relating to PD aetiology aetiology

see etiology.
, diagnosis, and prognosis; working party recommendations for the use of outcome measures in clinical practice; and a review of the evidence available regarding therapeutic processes. This latter section includes general treatment principles and evidence for specific treatment strategies, such as cueing strategies, improvement of gait, and falls prevention. A guide to the grading of the recommendations according to level of evidence is provided on p. 16. The document finishes with appendices that provide useful information about medications used in PD, 14 appendices of the measuring instruments recommended by the working party for use in PD (eg, Freezing of Gait questionnaire, Modified Parkinson's Activity Scale) and provides examples of cognitive movement strategies.

Sandra Brauer

The University of Queensland The University of Queensland (UQ) is the longest-established university in the state of Queensland, Australia, a member of Australia's Group of Eight, and the Sandstone Universities. It is also a founding member of the international Universitas 21 organisation.  
COPYRIGHT 2007 Australian Physiotherapy Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion




Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Appraisal: Clinical Practice Guidelines
Author:Brauer, Sandra
Publication:Australian Journal of Physiotherapy
Geographic Code:8AUST
Date:Dec 1, 2007
Previous Article:Quantitative Ultrasound (QUS).
Next Article:Acute pain.

Related Articles
Survey: Parkinson's symptoms respond poorly to drug Tx.
Four new Parkinson's disease guidelines hailed: review finds insufficient evidence to show that alternative therapies benefit Parkinson's patients.
Clinical Practice Guidelines in the Netherlands.
Neural transplantation for the treatment of Parkinson's disease.
Creatine to flex muscles in Parkinson's trial.
AM in call for more Parkinson's nurses.
City patients join Parkinson's trial; HEALTH: Sufferers can aid understanding of debilitating brain condition.
Practice parameters and clinical practice guidelines: science, politics, and problems.
Parkinson's plea; Mailbag.
Parkinson disease: current evidence for acute care management.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters